Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1681-1690 of 2933 for cancer

Edit search filters
  1. Docetaxel And Cyclophosphamide Compared To Anthracycline-Based Chemotherapy In Treating Women With HER2-Negative Breast Cancer

    Rochester, MN

  2. Phase I Dose Escalation Study For BAY 1251152 In Patients With Advanced Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Ruxolitinib In Combination With Pemetrexed/Cisplatin In Non Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  4. A Study Of Abemaciclib (LY2835219) In Women With HR+, HER2+ Locally Advanced Or Metastatic Breast Cancer

    Rochester, MN

  5. Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel In Pancreatic Cancer

    Scottsdale/Phoenix, AZ

  6. Risk-Based Therapy In Treating Younger Patients With Newly Diagnosed Liver Cancer

    Rochester, MN

  7. Avatar-Directed Chemotherapy In Treating Patients With Ovarian, Primary Peritoneal, Or Fallopian Tube Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. Efficacy Evaluation Of TheraSphere Following Failed First Line Chemotherapy In Metastatic Colorectal Cancer

    Rochester, MN

  9. Erlotinib Hydrochloride In Preventing Liver Cancer In Patients With Cirrhosis Of The Liver Undergoing Surgery

    Jacksonville, FL, Rochester, MN

  10. Phase II Study Of Tipifarnib In Squamous Head And Neck Cancer With HRAS Mutations

    Rochester, MN

.

Mayo Clinic Footer